|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.69 USD | +0.15% |
|
-2.80% | -17.68% |
| 01/07 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
| 01/07 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
Gilead agreed in 2020 to buy Trodelvy-maker Immunomedics for $21 billion. "Gilead Says Trodelvy Lung Cancer Trial Didn't Meet Primary Endpoint" at 8:47 a.m. ET incorrectly said Gilead agreed in 2022 to buy Immunomedics.
(END) Dow Jones Newswires
01-22-24 0917ET
| 1st Jan change | Capi. | |
|---|---|---|
| -17.68% | 8.31TCr | |
| +56.89% | 82TCr | |
| +39.52% | 63TCr | |
| -6.55% | 35TCr | |
| +15.99% | 32TCr | |
| +7.92% | 30TCr | |
| +13.74% | 24TCr | |
| +13.83% | 22TCr | |
| -0.49% | 22TCr | |
| +7.94% | 17TCr |
GILEAD SCIENCES, INC. 
